|
Market Closed -
Nasdaq
04:00:00 19/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 6.120 USD | +7.94% |
|
-12.57% | -56.87% |
| 09-04 | NextCure Enters Into Ninth Amendment To Lease Agreement And Vacates Premises At 8000 Virginia Manor Road | CI |
| 08-12 | RTW Biotech's Avere to go public in US in reverse merger with NextCure | AN |
| Market Cap | 28.01M 24.43M 23.07M 20.95M 39.24M 2.69B 39.41M 276M 107M 1.37B 105M 103M 4.4B | P/E 2026 * |
-0.97x | P/E 2027 * | -1.04x |
|---|---|---|---|---|---|
| Enterprise Value | 28.01M 24.43M 23.07M 20.95M 39.24M 2.69B 39.41M 276M 107M 1.37B 105M 103M 4.4B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
91.36% | Yield 2026 * |
-
| Yield 2027 * | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| NXTC | Delayed | |
CBOE
| NXTC | Real-time |
Last Transcript: NextCure, Inc.
| 1 day | +7.94% | ||
| 1 week | -12.57% | ||
| Current month | -4.23% | ||
| 1 month | -9.73% | ||
| 3 months | +202.97% | ||
| 6 months | -39.29% | ||
| Current year | -56.87% |
| 1 week | 5.54 |  | 7 |
| 1 month | 5.54 | | 8.64 |
| Current year | 1.55 | | 14.65 |
| 1 year | 1.55 | | 15.74 |
| 3 years | 1.55 | | 30.84 |
| 5 years | 1.55 | | 110.16 |
| 10 years | 1.55 | | 1,308 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Richman
CEO | Chief Executive Officer | 65 | 01/12/2015 |
Steven Cobourn
DFI | Director of Finance/CFO | 63 | 01/01/2018 |
Udayan Guha
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/03/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Richman
BRD | Director/Board Member | 65 | 01/12/2015 |
Elaine Jones
BRD | Director/Board Member | 71 | 01/12/2015 |
David Kabakoff
CHM | Chairman | 78 | 01/12/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/8/26 | Sell | Company | -30,000 | 0.6554% | ||
| 31/7/26 | Adar1 Capital Management LLC
| Buy | Company | 36,303 | 0.7931% | |
| 29/7/26 | Adar1 Capital Management LLC
| Buy | Company | 3,410 | 0.0944% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +7.94% | -12.57% | +8.51% | -61.94% | 28.01M | |
| -0.31% | +5.79% | +47.13% | +99.00% | 70.88B | |
| +0.39% | +2.06% | +39.38% | +78.27% | 62.49B | |
| +0.50% | +7.13% | +33.27% | +16.01% | 26.34B | |
| -3.21% | -7.27% | -17.10% | +356.10% | 26.21B | |
| -2.64% | -0.69% | -0.17% | -13.01% | 24.13B | |
| +0.71% | +8.03% | +25.03% | -12.74% | 20.72B | |
| -1.26% | -7.81% | +156.15% | +320.43% | 15.36B | |
| -0.22% | +3.99% | +45.54% | +172.46% | 14.46B | |
| +0.73% | +1.71% | -5.51% | +849.47% | 14.24B | |
| Average | +0.26% | +0.23% | +33.22% | +180.41% | 27.49B | |
| Weighted average by Cap. | -0.47% | +1.44% | +35.38% | +147.70% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -33.8M -29.47M -27.83M -25.27M -47.35M -3.24B -47.55M -333M -129M -1.65B -127M -124M -5.31B | -43.65M -38.06M -35.94M -32.64M -61.15M -4.19B -61.4M -431M -166M -2.13B -164M -160M -6.85B |
| Net Debt | - | - |
Employees
40
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | US$6.120 | +7.94% | 103,912 |
| 17/09/26 | US$5.670 | -5.97% | 106,853 |
| 16/09/26 | US$6.030 | -5.34% | 106,981 |
| 15/09/26 | US$6.370 | -4.07% | 157,560 |
| 14/09/26 | US$6.640 | -5.14% | 90,563 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
6.120USD
Average target price
20.00USD
Spread / Average Target
+226.80%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NXTC Stock
Select your edition
All financial news and data tailored to specific country editions
